Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226) |
---|
09/29/2004 | EP1019040B1 Aryl ureas for the treatment of inflammatory or immunomodulatory diseases |
09/29/2004 | EP0805804B1 Sulphonyl amino(thio)carbonyl-1,2,4-triazolin(thi)one derivatives, the production thereof and the use thereof as herbicides |
09/29/2004 | CN1533382A 哌嗪衍生物 Piperazine derivatives |
09/29/2004 | CN1533374A Substitutled cyclohexane-1,4-diamine derivatives |
09/29/2004 | CN1168727C Substituted benzimidazole |
09/29/2004 | CN1168721C 5-cyano-2-aminopyrimidine derivatives |
09/29/2004 | CN1168719C 6-phenylpyridyl-2-amine derivatives and pharmaceutical composition and use |
09/29/2004 | CN1168715C Novel benzene amine compound, its prepn. process and medicinal compsns. contg. them |
09/29/2004 | CN1168704C Aryl and heteroaryl cyclopropyl oximidoether and its application as bactericide and pesticide |
09/29/2004 | CN1168434C Cosmetic and pharmaceutical preparations containing photostable UV filters |
09/28/2004 | US6797838 Process for preparing homophthalate derivatives |
09/28/2004 | US6797833 Taxane derivatives having a tricyclic or tetracyclic core; remarkable properties in vitro; valuable antileukemia, antitumor and anticarcinogenic agents; human cancer cell line comparable to that of taxol and taxotere |
09/28/2004 | US6797712 Substituted amino-furan-2-yl-acetic acid and amino-thien-2-yl-acetic acid derivatives and their use in the treatment of migraine and pain |
09/28/2004 | US6797708 Enzyme inhibitors such as 4-(2-(1-benzhydryl-2-(2-((benzyl-sulfonyl)amino)ethyl)-5-chloro-1h-indol-3 -yl)ethoxy) benzoic acid, used as analgesics or antiinflammatory agents |
09/28/2004 | US6797504 For prevention and treatment of cancer, tumors, metastasis; drug screening |
09/23/2004 | WO2004081005A1 Melanin-concentrating hormone receptor antagonists and compositions and methods related thereto |
09/23/2004 | WO2004080999A1 Pyrazole compounds useful in the treatment of inflammation |
09/23/2004 | WO2004080990A1 C-glycoside derivatives and salts thereof |
09/23/2004 | WO2004080983A1 Novel lactams and uses thereof |
09/23/2004 | WO2004080982A1 Pyrazine compounds as transforming growth factor (tgf) inhibitors |
09/23/2004 | WO2004080981A1 Pyrimidin-2-one compounds and their use as dopamine d3 receptor ligands |
09/23/2004 | WO2004080976A1 Phthalazinone derivatives |
09/23/2004 | WO2004080973A1 Fused tri and tetra-cyclic pyrazole kinase inhibitors |
09/23/2004 | WO2004080972A1 Pirazole modulators of atp-binding cassette transporters |
09/23/2004 | WO2004080970A1 Novel bicyclic aromatic compounds, the production and use thereof in the form of drugs |
09/23/2004 | WO2004080968A1 6-substituted nicotinamide derivatives as opioid receptor antagonists |
09/23/2004 | WO2004080952A1 Phenylsulfonamide derivatives for treating alzheimer's disease |
09/23/2004 | WO2004080947A1 Imino ether derivative compounds and drugs containing the compounds as the active ingredient |
09/23/2004 | WO2004080480A1 Pharmaceutical preparations comprising acid-stabilised insulin |
09/23/2004 | WO2004080411A2 Melanin-concentrating hormone receptor antagonists and compositions and methods related thereto |
09/23/2004 | WO2004063185A8 Thiophene carboxamides as inhibitors of the enzyme ikk-2 |
09/23/2004 | WO2003079403A3 Oligo(ethylene glycol)-terminated 1,2-dithiolanes and their conjugates useful for preparing self-assembled monolayers |
09/23/2004 | US20040186287 heterocyclic imines such as 2-(2,6-difluorophenyl)-5-phenyl-3,4-dihydro-2H-pyrrole, formed by cyclocondensation, for use as insecticides or miticides |
09/23/2004 | US20040186170 Benzofuran derivatives, pharmaceutical composition containing the same, and a process for the preparation of the active ingredient |
09/23/2004 | US20040186159 used to treat glaucomatous optic neuropathy and/or lower and control intraocular pressure (IOP) associated with normal-tension glaucoma, ocular hypertension, and/or glaucoma in warm blooded animals, including man |
09/23/2004 | US20040186156 useful for solid tumors and leukemia; auto-immune diseases such as psoriasis, alopecia and multiple sclerosis; cardiovascular diseases such as stenoses, arterioscleroses and restenoses; infectious diseases caused by unicellular parasites; nephrological diseases, neurodegenerative diseases |
09/23/2004 | US20040186145 Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them |
09/23/2004 | US20040186140 Cyclic derivatives as modulators of chemokine receptor activity |
09/23/2004 | US20040186135 Substituted piperidine compounds |
09/23/2004 | US20040186134 Inhibitors of Factor Xa are useful as anticoagulants in the treatment of cardiovascular disorders associated with thromboses; e.g., 1,1-dimethylethyl 1-[1-(-2-(-3-[2-(5-Chloro-thiophen-2-yl)-ethenesulfonylamino]-2-oxo-piperidin-1-yl)-acetyl)-pyrrolidin-2- yl-methyl]-pyrrolidin-3-yl}-methyl-carbamate |
09/23/2004 | US20040186133 preferably antagonists used in the therapeutic and/or preventive treatment of disfunctions of the heart, kidney, respiratory system, central nervous system |
09/23/2004 | US20040186125 E.g , 3-cyclohexyl-2-furan-3-yl-1Hindole-5-carboxylic acid; hepatitis C viricides that target RNA dependent RNA polymerases (Ns5B) in mammals, an enzyme essential to viral replication; used in conjunction with an mmunomodulatory agent, such as beta -, delta - gamma -, and omega -interferon |
09/23/2004 | US20040186124 Anticarcinogenic agents, antitumor agents treating cancer of breast, head , neck, gastrointestinal or stomach, leukemia, ovaries, bronchi, lung or pancreas |
09/23/2004 | US20040186118 Chk-, Pdk- and Akt-inhibitory pyrimidines, their production and use as pharmaceutical agents |
09/23/2004 | US20040186113 Heterocyclic amines for the treatment of conditions associated with gsk-3 |
09/23/2004 | US20040186099 Novel heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicine |
09/23/2004 | US20040186098 Method for preventing and treating hearing loss using sensorineurotrophic compounds |
09/23/2004 | US20040186097 such as N-phenyl-3-[[4-(phenylmethyl)-1-piperidinyl]methyl]-1-piperidinecarboxamide for prevention of asthma and allergies |
09/23/2004 | DE10341535A1 New N,N-disubstituted (hetero)arylsulfonamide derivatives are gamma-secretase inhibitors useful for treatment or prophylaxis of Alzheimer's disease |
09/23/2004 | DE10311065A1 New 1-(cyclic amino-alkyl)-pyrimidin-2(1H)-one derivatives, are selective dopamine D3 receptor ligands useful for treating CNS disorders, especially schizophrenia or depression |
09/23/2004 | DE10310278A1 New N-(benzazinyl)-(hetero)aralkylamine derivatives, are inhibitors of factor Xa and/or related serine proteases, useful e.g. as antithrombotic agents and intermediates |
09/23/2004 | CA2518986A1 Imino ether derivative compounds and drugs containing the compounds as the active ingredient |
09/23/2004 | CA2518194A1 6-substituted nicotinamide derivatives as opioid receptor antagonists |
09/23/2004 | CA2517885A1 Fused tri and tetra-cyclic pyrazole kinase inhibitors |
09/23/2004 | CA2517720A1 Pyrazine compounds as transforming growth factor (tgf) inhibitors |
09/22/2004 | EP1460062A1 Nitrogenous cyclic ketone derivative, process for producing the same, and use |
09/22/2004 | EP1458718A1 Quinolinones as prostaglandin receptor ligands |
09/22/2004 | EP1458715A1 Novel compounds |
09/22/2004 | EP1458714A1 3,4-dihydro-1h-isoquinoloin-2-yl-derivatives |
09/22/2004 | EP1458703A1 Isochroman compounds for treatment of cns disorders |
09/22/2004 | EP1458691A2 Benzodiazepine derivatives, preparation thereof and use thereof |
09/22/2004 | EP1458685A2 Substituted phenyl derivatives |
09/22/2004 | EP1458684A2 Therapeutic heterocycles |
09/22/2004 | EP1458683A1 Heteroaryl-substituted aminocyclohexane derivatives |
09/22/2004 | EP1458386A1 Aroyl pyrrole heteroeryl and methanols useful for treating a central nervous system disorder |
09/22/2004 | EP1458382A1 Amide derivatives as gk activators |
09/22/2004 | EP1458380A1 Cis-2,4,5- triphenyl-imidazolines and their use in the treatment of tumors |
09/22/2004 | EP1458379A1 Hydroxyphenyl-pyrazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
09/22/2004 | EP1458375A2 Compositions for decreasing activity of hormone-sensitive lipase |
09/22/2004 | EP1458374A2 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
09/22/2004 | EP1192165B1 Substituted heterocycle fused gamma-carbolines |
09/22/2004 | EP1189904B1 Substituted heterocycle fused gamma-carbolines |
09/22/2004 | EP1169320B1 Farnesyl transferase inhibitors having a pyrrole structure and process for preparation thereof |
09/22/2004 | EP1140860B1 Pyrimidine compounds |
09/22/2004 | EP1100781B1 High affinity ligands for nociceptin receptor orl-1 |
09/22/2004 | CN1531534A 2-heteroaryl-3,4-dihydro-2H-pyrrole derivatives and use thereof as pesticides |
09/22/2004 | CN1531531A Novel arylsusfonamide compounds for treatment of obesity, type II diabetes and CNS-disorders |
09/22/2004 | CN1531527A Carbazole derivatives and their use as neuropeptide Y5 receptor ligands |
09/22/2004 | CN1530366A Sulphonic acid amide for regulating bast peptide activity and derivative thereof |
09/22/2004 | CN1167687C Arylpyridazinones as prostaglandin endoperoxide H synthase biosynthesis inhibitors |
09/22/2004 | CN1167686C Novel benzimidazole derivatives and pharmaceutical compsns. comprising these compounds |
09/22/2004 | CN1167680C Fused-ring compounds and use thereof as drugs |
09/22/2004 | CN1167673C Fluorovinyloxyacetamides, process for preparing the same and herbicidal composition comprising the same |
09/22/2004 | CN1167416C Use of glucose uptake enhancer for reducing post-ischemic injury of heart |
09/21/2004 | US6794544 Method for the preparation of tetrahydrobenzothiepines |
09/21/2004 | US6794523 Anticancer agents, antitumor agents; leukemia |
09/21/2004 | US6794511 An enzyme inhibitors of metalloprotease; treating connective tissue degradation caused by inflammation or tumor |
09/21/2004 | US6794471 Acrylic ester compound usage thereof |
09/21/2004 | US6794404 Viral polymerase inhibitors |
09/21/2004 | US6794393 Tyrosine kinase inhibitors |
09/21/2004 | US6794386 β-amino acid compounds as integrin antagonists |
09/21/2004 | US6794336 Herbicidal substituted pyridines, their preparation, and their use as herbicides and plant growth regulators |
09/21/2004 | CA2200316C Imidazole derivative |
09/21/2004 | CA2076226C Substituted 1-pyrimidinylacetamide compounds |
09/21/2004 | CA2033143C Alkyl esters of 5-heterocyclic-pyridine-2,3-dicarboxylate acids, 5-heterocyclic 2-(2-imidazoline-2-yl)pyridines, useful as herbicidal agents and methods for the preparation thereof |
09/16/2004 | WO2004078748A2 Novel bicyclic urea derivatives useful in the treatment of cancer and other disorders |
09/16/2004 | WO2004078745A1 Biaryltetrahydroisoquinoline piperidines as selective mch receptor antagonists for the treatment of obesity and related disorders |
09/16/2004 | WO2004078733A1 Quinazolines useful as modulators of ion channels |
09/16/2004 | WO2004078732A1 N-aryl heteroaromatic products, compositions containing same and use thereof |
09/16/2004 | WO2004078731A1 Quinoline-carboxylic acids and the derivatives thereof, a focused library |